198 related articles for article (PubMed ID: 23258240)
1. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
[TBL] [Abstract][Full Text] [Related]
3. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A
Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421
[TBL] [Abstract][Full Text] [Related]
4. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.
Petta S; Amato MC; Di Marco V; Cammà C; Pizzolanti G; Barcellona MR; Cabibi D; Galluzzo A; Sinagra D; Giordano C; Craxì A
Aliment Pharmacol Ther; 2012 Jan; 35(2):238-47. PubMed ID: 22117531
[TBL] [Abstract][Full Text] [Related]
6. Association between non-alcoholic fatty liver disease and liver function/injury markers with metabolic syndrome components in class III obese individuals.
Chaves GV; Souza DS; Pereira SE; Saboya CJ; Peres WA
Rev Assoc Med Bras (1992); 2012; 58(3):288-93. PubMed ID: 22735219
[TBL] [Abstract][Full Text] [Related]
7. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
Targher G; Bertolini L; Padovani R; Poli F; Scala L; Zenari L; Zoppini G; Falezza G
J Endocrinol Invest; 2006 Jan; 29(1):55-60. PubMed ID: 16553034
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
10. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
[TBL] [Abstract][Full Text] [Related]
11. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
[TBL] [Abstract][Full Text] [Related]
13. Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease.
Eraslan S; Kizilgul M; Uzunlulu M; Colak Y; Ozturk O; Tuncer I
Minerva Med; 2013 Aug; 104(4):447-53. PubMed ID: 24008607
[TBL] [Abstract][Full Text] [Related]
14. [Elastography efficiency in the liver fibrosis determination in patients with nonalcoholic fatty liver disease].
Topil'skaia NV; Morozov SV; Isakov VA; Trufanova IuM; Kaganov BS
Eksp Klin Gastroenterol; 2011; (6):26-31. PubMed ID: 22168074
[TBL] [Abstract][Full Text] [Related]
15. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
16. Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance.
Ozcelik F; Yuksel C; Arslan E; Genc S; Omer B; Serdar MA
Arch Med Res; 2013 May; 44(4):273-80. PubMed ID: 23602473
[TBL] [Abstract][Full Text] [Related]
17. The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study.
Henry RM; Ferreira I; Dekker JM; Nijpels G; Scheffer PG; Stehouwer CD
J Hum Hypertens; 2009 Nov; 23(11):718-27. PubMed ID: 19279658
[TBL] [Abstract][Full Text] [Related]
18. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
19. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
